BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-10 out of 45 found
  Current Search:      

HTML
100%
J&J Buys Stake In Elan
NEW BRUNSWICK, N.J.

(AP) - Johnson & Johnson announced it will take an 18.4 percent stake Ireland-based drug developer Elan Corp.

with a $1 billion investment.

The news sent Elan's shares soaring in premarket activity.

Drug Discovery and Development:  Jul 4 2009 7:46AM Find similar documents
HTML
100%
Roche Leaves PhRMA
Hoffman La Roche is ending its membership in the Pharmaceutical Research and Manufacturers Association (PhRMA), according to a report in The Star-Ledger.

Composed of over thirty of the largest pharmaceutical and biotechnology companies,...

Drug Discovery and Development:  Jul 4 2009 7:46AM Find similar documents
HTML
100%
J&J Wins $1.67B Remicade Infringement Suit
LOS ANGELES (AP) - A unit of Johnson & Johnson said Monday that a federal jury has ordered Abbott Laboratories to pay $1.67 billion in a patent infringement suit over the companies' rheumatoid arthritis drugs.

Abbott's best-selling...

Drug Discovery and Development:  Jul 4 2009 7:46AM Find similar documents
HTML
100%
GSK Nausea Drug Rejected By FDA
TRENTON, N.J.

(AP) - The U.S.

Food and Drug Administration has rejected GlaxoSmithKline PLC's application to approve an experimental drug for nausea and vomiting, saying more data is needed.

The British drugmaker said Tuesday that it...

Drug Discovery and Development:  Jun 28 2009 3:59AM Find similar documents
HTML
100%
Merck and DNDi Partner for Neglected Tropical Diseases
On the eve of an international meeting bringing together 200 African researchers to discuss progress on research for neglected tropical diseases (NTD), Merck & Co., Inc.

and the not-for-profit Drugs for Neglected Diseases...

Drug Discovery and Development:  Jun 28 2009 3:58AM Find similar documents
HTML
100%
Pig Fibroblasts Turned Into Stem Cells
For years, proponents have touted the benefits of embryonic stem cell research, but the potential therapies still face hurdles.

Side effects such as tumor development, a lack of an effective and long-term animal model to test new therapies...

Drug Discovery and Development:  Jun 26 2009 7:51PM Find similar documents
HTML
100%
MicroRNA May Halt Cancer
A new study suggests that delivering small RNAs, known as microRNAs, to cancer cells could help to stop the disease in its tracks.

MicroRNAs control gene expression and are commonly lost in cancerous tumors.

Researchers have shown that...

Drug Discovery and Development:  Jun 24 2009 8:44AM Find similar documents
HTML
100%
Researchers Find New Cancer Biomarker
researchers have developed a new breast cancer diagnostic marker that could enable physicians to more easily determine which patients have a less aggressive form of the disease that may not require chemotherapy treatment.

The marker has...

Drug Discovery and Development:  Jun 24 2009 8:44AM Find similar documents
HTML
100%
Water Gates May Hold Key to Cancer
The flow of water into and out from the cell may play a crucial role in several types of cancer.

Scientists at the University of Gothenburg, Sweden, have now found the gate that regulates the flow of water into yeast cells.

The discovery...

Drug Discovery and Development:  Jun 24 2009 8:44AM Find similar documents
HTML
100%
Two Possible Liver Cancer Drugs Found
Ohio State University cancer researchers have used computational and genomic methods to identify possible anti-cancer agents that may block a particular kind of tumor behavior.

The agents target multiple genes associated with that behavior...

Drug Discovery and Development:  Jun 24 2009 8:44AM Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.